[go: up one dir, main page]

WO2002048368A3 - Proteines associees a la croissance, a la differenciation et a la mort cellulaire - Google Patents

Proteines associees a la croissance, a la differenciation et a la mort cellulaire Download PDF

Info

Publication number
WO2002048368A3
WO2002048368A3 PCT/US2001/047871 US0147871W WO0248368A3 WO 2002048368 A3 WO2002048368 A3 WO 2002048368A3 US 0147871 W US0147871 W US 0147871W WO 0248368 A3 WO0248368 A3 WO 0248368A3
Authority
WO
WIPO (PCT)
Prior art keywords
death
differentiation
cell growth
proteins associated
cgdd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/047871
Other languages
English (en)
Other versions
WO2002048368A2 (fr
Inventor
Henry Yue
Li Ding
Catherine M Tribouley
Bao Tran
Brendan M Duggan
Cynthia D Honchell
Mariah R Baughn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Priority to JP2002550083A priority Critical patent/JP2005502305A/ja
Priority to CA002430906A priority patent/CA2430906A1/fr
Priority to AU2002227373A priority patent/AU2002227373A1/en
Priority to EP01996229A priority patent/EP1385954A2/fr
Publication of WO2002048368A2 publication Critical patent/WO2002048368A2/fr
Anticipated expiration legal-status Critical
Publication of WO2002048368A3 publication Critical patent/WO2002048368A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des protéines humaines associées à la croissance, à la différenciation et à la mort cellulaire (CGDD) et des polynucléotides identifiant et codant CGDD. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne également des méthodes de diagnostic, de traitement ou de prévention de troubles associés à une expression anormale de CGDD.
PCT/US2001/047871 2000-12-14 2001-12-11 Proteines associees a la croissance, a la differenciation et a la mort cellulaire Ceased WO2002048368A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2002550083A JP2005502305A (ja) 2000-12-14 2001-12-11 細胞増殖、細胞分化および細胞死に関連するタンパク質
CA002430906A CA2430906A1 (fr) 2000-12-14 2001-12-11 Proteines associees a la croissance, a la differenciation et a la mort cellulaire
AU2002227373A AU2002227373A1 (en) 2000-12-14 2001-12-11 Proteins associated with cell growth, differentiation, and death
EP01996229A EP1385954A2 (fr) 2000-12-14 2001-12-11 Proteines associees a la croissance, a la differenciation et a la mort cellulaire

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25575400P 2000-12-14 2000-12-14
US60/255,754 2000-12-14
US25760500P 2000-12-21 2000-12-21
US60/257,605 2000-12-21
US26285501P 2001-01-19 2001-01-19
US60/262,855 2001-01-19

Publications (2)

Publication Number Publication Date
WO2002048368A2 WO2002048368A2 (fr) 2002-06-20
WO2002048368A3 true WO2002048368A3 (fr) 2003-11-27

Family

ID=27400894

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/047871 Ceased WO2002048368A2 (fr) 2000-12-14 2001-12-11 Proteines associees a la croissance, a la differenciation et a la mort cellulaire

Country Status (5)

Country Link
EP (1) EP1385954A2 (fr)
JP (1) JP2005502305A (fr)
AU (1) AU2002227373A1 (fr)
CA (1) CA2430906A1 (fr)
WO (1) WO2002048368A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1399474A2 (fr) * 2000-12-15 2004-03-24 Eli Lilly And Company Nouvelles proteines secretees et leurs utilisations
JP2005521382A (ja) * 2001-09-28 2005-07-21 インサイト・ゲノミックス・インコーポレイテッド 細胞成長、分化および細胞死関連タンパク質

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HUANG SUI ET AL: "Shape-dependent control of cell growth, differentiation, and apoptosis: Switching between attractors in cell regulatory networks", EXPERIMENTAL CELL RESEARCH, SAN DIEGO, CA, US, vol. 261, no. 1, 25 November 2000 (2000-11-25), pages 91 - 103, XP002205154, ISSN: 0014-4827 *
LOMAX MI ET AL: "Differential display and gene arrays to examine auditory plasticity", HEARING RESEARCH, vol. 147, - September 2000 (2000-09-01), pages 293 - 302, XP002220427 *

Also Published As

Publication number Publication date
CA2430906A1 (fr) 2002-06-20
EP1385954A2 (fr) 2004-02-04
JP2005502305A (ja) 2005-01-27
AU2002227373A1 (en) 2002-06-24
WO2002048368A2 (fr) 2002-06-20

Similar Documents

Publication Publication Date Title
WO2001012662A3 (fr) Proteines associees a la membrane
WO2000018922A3 (fr) Proteines humaines associees a des glucides
WO2001020004A3 (fr) Proteines phosphatase et proteines kinase
WO2000026245A3 (fr) Proteines de transport membranaire
WO2003008553A3 (fr) Proteines associees a la croissance, a la differenciation et a la mort cellulaires
WO2000017355A3 (fr) Proteines humaines associees au cytosquelette
WO2003014322A3 (fr) Proteines associees a la croissance, la differentiation et la mort cellulaires
WO2000014251A3 (fr) Transferases humaines
WO2002097060A3 (fr) Proteines associees aux carbohydrates
WO2001096546A3 (fr) Proteine-phosphatases
WO2003077875A3 (fr) Proteines associees a la croissance, a la differenciation et a la mort cellulaires
WO2001085942A3 (fr) Proteines associees au cytosquelette
WO2002072830A3 (fr) Proteines associees a la croissance, a la differenciation et a la mort cellulaire
WO2002010363A3 (fr) Proteines phosphatases
WO2002097032A3 (fr) Proteines associees a la croissance, a la differenciation et a la mort cellulaire
WO2002102310A3 (fr) Proteines associees a la croissance, la differenciation et la mort de cellules
WO2004031364A3 (fr) Proteines associees a la croissance, a la differenciation, et a la mort des cellules
WO2000008155A3 (fr) Proteines associees a un recepteur humain
WO2001019860A3 (fr) Proteines associees a la differenciation cellulaire
WO2002024924A3 (fr) Proteine phosphatases
WO2003095622A8 (fr) Proteines associees a la croissance, la differentiation et la mort cellulaires
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2000060082A3 (fr) Proteines associees a une vesicule
WO2003027263A3 (fr) Proteines associees a la croissance, a la differenciation et a la mort des cellules
WO2001094391A3 (fr) Proteines de signalisation intracellulaires

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001996229

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002550083

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2430906

Country of ref document: CA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001996229

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001996229

Country of ref document: EP